Search Results - "Kumar, Ram Pravin"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Fluorescence‐Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids by Yau, Jia Ning Nicolette, Yempala, Thirumal, Muthuramalingam, Ram Pravin Kumar, Giustarini, Giulio, Teng, Germaine, Ang, Wee Han, Gibson, Dan, Adriani, Giulia, Pastorin, Giorgia

    Published in Advanced healthcare materials (01-08-2024)
    “…The limited recapitulation of critical cancer features in 2D cultures causes poor translatability of preclinical results from in vitro assays to in vivo tumor…”
    Get full text
    Journal Article
  2. 2

    Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies by Ranjithkumar, R., Saravanan, K., Balaji, B., Hima, S., Sreeja, S., Timane, S. R., Ram Pravin Kumar, M., Kabilan, S., Ramanathan, M.

    Published in Journal of chemotherapy (Florence) (01-12-2021)
    “…Eight novel ERβ selective daidzein analogues (NCE1-8) were synthesized and their anti-cancer activity was evaluated by in vitro and in vivo methods…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles by Ou, Yi-Hsuan, Liang, Jeremy, Chng, Wei Heng, Muthuramalingam, Ram Pravin Kumar, Ng, Zi Xiu, Lee, Choon Keong, Neupane, Yub Raj, Yau, Jia Ning Nicolette, Zhang, Sitong, Lou, Charles Kang Liang, Huang, Chenyuan, Wang, Jiong-Wei, Pastorin, Giorgia

    Published in Pharmaceutics (01-08-2022)
    “…In drug delivery, the development of nanovesicles that combine both synthetic and cellular components provides added biocompatibility and targeting specificity…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection by Rajan, Ravi Kumar, Kumar, Ram Pravin, Ramanathan, M.

    “…Cerebral ischemia is one of the leading causes of death and disability worldwide. The only FDA-approved treatment is recanalization with systemic tissue…”
    Get full text
    Journal Article